Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101451383 | 10145138 | 3 | F | 2013 | 20150923 | 20140501 | 20150930 | EXP | US-BIOGENIDEC-2014BI039347 | BIOGEN | 48.00 | YR | F | Y | 0.00000 | 20150930 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101451383 | 10145138 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | POWDER FOR SOLUTION FOR INJECTION | /wk | ||||||
| 101451383 | 10145138 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 101451383 | 10145138 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 101451383 | 10145138 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | SOLUTION FOR INJECTION | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101451383 | 10145138 | 1 | Multiple sclerosis |
| 101451383 | 10145138 | 2 | Multiple sclerosis |
| 101451383 | 10145138 | 3 | Multiple sclerosis |
| 101451383 | 10145138 | 4 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101451383 | 10145138 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101451383 | 10145138 | Chills | |
| 101451383 | 10145138 | Depressed mood | |
| 101451383 | 10145138 | Diarrhoea | |
| 101451383 | 10145138 | Emotional distress | |
| 101451383 | 10145138 | Fear | |
| 101451383 | 10145138 | Gait disturbance | |
| 101451383 | 10145138 | Incorrect product storage | |
| 101451383 | 10145138 | Influenza like illness | |
| 101451383 | 10145138 | Injection site haemorrhage | |
| 101451383 | 10145138 | Injection site pain | |
| 101451383 | 10145138 | Malaise | |
| 101451383 | 10145138 | Migraine | |
| 101451383 | 10145138 | Mobility decreased | |
| 101451383 | 10145138 | Nervousness | |
| 101451383 | 10145138 | Pain | |
| 101451383 | 10145138 | Product colour issue | |
| 101451383 | 10145138 | Skin disorder | |
| 101451383 | 10145138 | Tremor | |
| 101451383 | 10145138 | Venous injury | |
| 101451383 | 10145138 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101451383 | 10145138 | 1 | 2013 | 2013 | 0 | |
| 101451383 | 10145138 | 2 | 2013 | 2013 | 0 | |
| 101451383 | 10145138 | 3 | 20130201 | 0 | ||
| 101451383 | 10145138 | 4 | 201508 | 0 |